ARTICLE | Politics, Policy & Law
PhRMA, BIO fighting tariffs
Trump's threat to impose 25% pharma tariffs has alarmed biopharma companies, spurred talk of mitigation strategies
March 21, 2025 11:21 PM UTC
If President Donald Trump imposes planned 25% tariffs on pharmaceutical imports, drug companies would incur tens of billions of dollars in added costs, and consumers would face both higher prices and shortages of essential medicines.
Lobbying by pharmaceutical companies might prompt Trump to delay tariffs, while backlash from falling share prices or public anger over higher prices and shortages could trigger a quick reversal...